Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bacon

Showing results (511-520 of 609) with videos related to

Pageof 61
Sort By:
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|January 1, 1988
Interlaboratory comparison of hydrophone calibrationsR C Preston, D R Bacon, S S Corbett, et al.
Haematologica|April 11, 2000
Cell surface expression of HFE protein in epithelial cells, macrophages, and monocytesS Parkkila, A K Parkkila, A Waheed, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosisR E Fleming, C C Holden, S Tomatsu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2002
Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosisRobert E Fleming, John R Ahmann, Mary C Migas, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2000
Pharmacokinetics and hepatic disposition of bis[1-(ethoxycarbonyl)propyl]5-acetylamino-2,4,6-triiodoisophthalate in rats and isolated perfused rat liversY Liu, E R Bacon, K Ballinger, et al.
Gastroenterology|April 1, 1995
Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis CJ K Olynyk, K R Reddy, A M Di Bisceglie, et al.
Neuropharmacology|September 25, 2015
3-(1'-Cyclobutylspiro[4H-1,3-benzodioxine-2,4'-piperidine]-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one (CEP-32215), a new wake-promoting histamine H3 antagonist/inverse agonistRobert L Hudkins, John A Gruner, Rita Raddatz, et al.
NPJ Precision Oncology|March 30, 2024
Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer-a call for enhanced surveillance strategiesEliza R Bacon, Kena Ihle, Weihua Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosisAbdul Waheed, Jeffrey H Grubb, Xiao Yan Zhou, et al.
The New England Journal of Medicine|July 13, 2007
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3Mitchell L Shiffman, Fredy Suter, Bruce R Bacon, et al.
Pageof 61

Showing results (511-520 of 609) with videos related to

Sort By:
Pageof 61
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|January 1, 1988
Interlaboratory comparison of hydrophone calibrationsR C Preston, D R Bacon, S S Corbett, et al.
Haematologica|April 11, 2000
Cell surface expression of HFE protein in epithelial cells, macrophages, and monocytesS Parkkila, A K Parkkila, A Waheed, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosisR E Fleming, C C Holden, S Tomatsu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2002
Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosisRobert E Fleming, John R Ahmann, Mary C Migas, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2000
Pharmacokinetics and hepatic disposition of bis[1-(ethoxycarbonyl)propyl]5-acetylamino-2,4,6-triiodoisophthalate in rats and isolated perfused rat liversY Liu, E R Bacon, K Ballinger, et al.
Gastroenterology|April 1, 1995
Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis CJ K Olynyk, K R Reddy, A M Di Bisceglie, et al.
Neuropharmacology|September 25, 2015
3-(1'-Cyclobutylspiro[4H-1,3-benzodioxine-2,4'-piperidine]-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one (CEP-32215), a new wake-promoting histamine H3 antagonist/inverse agonistRobert L Hudkins, John A Gruner, Rita Raddatz, et al.
NPJ Precision Oncology|March 30, 2024
Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer-a call for enhanced surveillance strategiesEliza R Bacon, Kena Ihle, Weihua Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosisAbdul Waheed, Jeffrey H Grubb, Xiao Yan Zhou, et al.
The New England Journal of Medicine|July 13, 2007
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3Mitchell L Shiffman, Fredy Suter, Bruce R Bacon, et al.
Pageof 61